NCT03518203 · Interventional trial
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
Overall registry status Completed
Phase 2
Conditions Atypical Hemolytic Uremic Syndrome, Multiple Organ Dysfunction Syndrome, Thrombotic Microangiopathies
Delaware Valley sites
- Children's Hospital of Philadelphia (CHOP) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory